These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 29723590
1. Unclassifiable CD20-negative Testicular Diffuse Large B-cell Lymphoma. Garrido-Abad P, García-Martín L, Villar-Zarra K, Díaz-Menéndez A, Fernández-Arjona M. Urology; 2018 Jul; 117():e3-e4. PubMed ID: 29723590 [Abstract] [Full Text] [Related]
2. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge. AbdullGaffar B, Seliem RM. Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264 [Abstract] [Full Text] [Related]
3. [Clinicopathologic features and expression of OCT4 protein in testicular diffuse large B cell lymphoma]. Chen YP, Zhu WF, Chen LF, Lu JP, He TM, Fu WD, Xu CW, Chen G. Zhonghua Bing Li Xue Za Zhi; 2017 Jun 08; 46(6):383-387. PubMed ID: 28591984 [Abstract] [Full Text] [Related]
4. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly]. Xu FP, Liu YH, Zhuang HG, Luo DL, Li L, Zhang F, Luo XL, Du X, Li WY, Chen Q. Zhonghua Bing Li Xue Za Zhi; 2011 Sep 08; 40(9):616-21. PubMed ID: 22177246 [Abstract] [Full Text] [Related]
5. [Primary diffuse large B-cell lymphoma of testis: a clinicopathologic study of 14 cases]. Li D, Mi C, Zhao Y, Wang YL, Ma Y, Li YY, Xiang MH. Zhonghua Bing Li Xue Za Zhi; 2007 Jul 08; 36(7):461-5. PubMed ID: 17845759 [Abstract] [Full Text] [Related]
6. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases. Li J, Zhao S, Wang J, Chen J, Wen W, Zhang Q. Tumour Biol; 2016 Mar 08; 37(3):3619-37. PubMed ID: 26459310 [Abstract] [Full Text] [Related]
7. Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab. Rasheed AA, Samad A, Raheem A, Hirani SI, Shabbir- Moosajee M. Asian Pac J Cancer Prev; 2018 Feb 26; 19(2):331-335. PubMed ID: 29479962 [Abstract] [Full Text] [Related]
8. Molecular pathological analysis of testicular diffuse large cell lymphomas. Hyland J, Lasota J, Jasinski M, Petersen RO, Nordling S, Miettinen M. Hum Pathol; 1998 Nov 26; 29(11):1231-9. PubMed ID: 9824100 [Abstract] [Full Text] [Related]
9. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases]. Wang WY, Ma ZG, Li GD, Liu WP, Zhong L, Wang Y, Li JM, Li L, Jiang W, Tang Y, Liao DY. Zhonghua Bing Li Xue Za Zhi; 2006 Sep 26; 35(9):529-34. PubMed ID: 17134546 [Abstract] [Full Text] [Related]
10. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Qunaj L, Castillo JJ, Olszewski AJ. Leuk Lymphoma; 2018 Jun 26; 59(6):1375-1383. PubMed ID: 29019447 [Abstract] [Full Text] [Related]
11. CD20 negative primary diffuse large B cell lymphoma of breast: Role of Pax-5. Shukla S, Awasthi NP, Singh P, Husain N. J Cancer Res Ther; 2015 Jun 26; 11(3):658. PubMed ID: 26458662 [Abstract] [Full Text] [Related]
12. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns]. Wang L, Wang W, Li X, Guo Y, Zhu X. Zhonghua Bing Li Xue Za Zhi; 2014 May 26; 43(5):307-12. PubMed ID: 25030862 [Abstract] [Full Text] [Related]
13. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options. Castillo JJ, Chavez JC, Hernandez-Ilizaliturri FJ, Montes-Moreno S. Expert Rev Hematol; 2015 Jun 26; 8(3):343-54. PubMed ID: 25641215 [Abstract] [Full Text] [Related]
14. Immunofluorescent labeling of CD20 tumor marker with quantum dots for rapid and quantitative detection of diffuse large B-cell non-Hodgkin's lymphoma. Shariatifar H, Hakhamaneshi MS, Abolhasani M, Ahmadi FH, Roshani D, Nikkhoo B, Abdi M, Ahmadvand D. J Cell Biochem; 2019 Mar 26; 120(3):4564-4572. PubMed ID: 30302797 [Abstract] [Full Text] [Related]
15. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study. Chu PG, Loera S, Huang Q, Weiss LM. Am J Clin Pathol; 2006 Oct 26; 126(4):534-44. PubMed ID: 16938666 [Abstract] [Full Text] [Related]
16. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype. Li D, Xie P, Mi C. Pathol Res Pract; 2010 Sep 15; 206(9):611-5. PubMed ID: 20627604 [Abstract] [Full Text] [Related]
17. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children]. Yang WP, Zhu CD, Gong LP, Lü BB, Zou Y, Zhong HS, Xiao Q, Wu Y, Xu HY, Zeng ST, Huang H. Zhonghua Bing Li Xue Za Zhi; 2009 Nov 15; 38(11):759-64. PubMed ID: 20079016 [Abstract] [Full Text] [Related]
18. Clinical and pathological features of testicular diffuse large B-cell lymphoma: a heterogeneous disease. Kuper-Hommel MJ, Janssen-Heijnen ML, Vreugdenhil G, Krol AD, Kluin-Nelemans HC, Coebergh JW, van Krieken JH. Leuk Lymphoma; 2012 Feb 15; 53(2):242-6. PubMed ID: 21787261 [Abstract] [Full Text] [Related]
19. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy. Maeshima AM, Taniguchi H, Fukuhara S, Morikawa N, Munakata W, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Tsuda H. Am J Surg Pathol; 2013 Apr 15; 37(4):563-70. PubMed ID: 23426122 [Abstract] [Full Text] [Related]
20. Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL. Suzuki Y, Yoshida T, Wang G, Togano T, Miyamoto S, Miyazaki K, Iwabuchi K, Nakayama M, Horie R, Niitsu N, Sato Y, Nakamura N. Ann Hematol; 2012 Jul 15; 91(7):997-1005. PubMed ID: 22249209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]